Cargando…
Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML
Treatment failure in AML is often attributed to P-glycoprotein-associated multidrug resistance. However, the importance of increased DNA repair in resistant cells is becoming more apparent. In order to investigate the ability of the DNA repair inhibitor aphidicolin to modulate drug resistance, we co...
Autores principales: | Sargent, J M, Elgie, A W, Williamson, C J, Lewandowicz, G M, Taylor, C G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363802/ https://www.ncbi.nlm.nih.gov/pubmed/11237390 http://dx.doi.org/10.1054/bjoc.2000.1639 |
Ejemplares similares
-
Aphidicolin markedly increases the platinum sensitivity of cells from primary ovarian tumours.
por: Sargent, J. M., et al.
Publicado: (1996) -
Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML
por: Zhang, Feifei, et al.
Publicado: (2022) -
Structural basis for inhibition of DNA replication by aphidicolin
por: Baranovskiy, Andrey G., et al.
Publicado: (2014) -
Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562
por: Sargent, J M, et al.
Publicado: (2001) -
Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML
por: Kurata, Morito, et al.
Publicado: (2016)